Crestline Management’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Crestline Management’s Portfolio SYNH Stock Details SYNH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-12,644	Closed	-$1.11M	–	287
2021 Q3	$1.11M	Buy	12,644 +7,017	+125%	+$635K	0.1%	126
2021 Q2	$504K	Buy	+5,627	New	+$475K	0.04%	119

Other funds holding SYNH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Crestline Management's SYNH Position: Q4 2021 in Review

Crestline Management sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q4 2021, closing a stake of 12,644 shares — an estimated $1.11M sold.

Crestline Management first reported a position in SYNH in Q2 2021 and held it in 2 quarters. The position peaked at $1.11M in Q3 2021. 378 funds tracked by Wall St. Rank hold SYNH as of Q4 2021.

Crestline Management reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q4 2021 after selling out during the quarter.
Crestline Management sold 12,644 Syneos Health, Inc. Class A Common Stock shares in Q4 2021, an estimated $1.11M.
Crestline Management first reported a position in Syneos Health, Inc. Class A Common Stock in Q2 2021 and held it in 2 quarters.
Crestline Management's Syneos Health, Inc. Class A Common Stock position peaked at $1.11M in Q3 2021.
378 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q4 2021.

Based on Crestline Management's 13F filing for Q4 2021, filed 14 Feb 2022.